Clovis Oncology (CLVS) - NASDAQ
From other sites
Company Description
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. The company has three product candidates in its clinical development pipeline: CO-1686, an oral epidermal... More
Sector: Healthcare
Industry: Biotechnology
Country: United States